Kurt Beam
Concepts (334)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Calcium Channels, L-Type | 58 | 2022 | 115 | 9.220 |
Why?
| Ryanodine Receptor Calcium Release Channel | 38 | 2023 | 71 | 6.690 |
Why?
| Calcium | 58 | 2023 | 1203 | 4.240 |
Why?
| Calcium Channels | 48 | 2012 | 160 | 4.160 |
Why?
| Muscle Fibers, Skeletal | 27 | 2022 | 187 | 3.690 |
Why?
| Muscle, Skeletal | 45 | 2023 | 1614 | 3.390 |
Why?
| Calcium Signaling | 18 | 2021 | 247 | 3.070 |
Why?
| Ion Channel Gating | 18 | 2015 | 94 | 2.960 |
Why?
| Muscle Contraction | 35 | 2012 | 422 | 2.540 |
Why?
| Muscles | 38 | 2008 | 322 | 2.130 |
Why?
| Excitation Contraction Coupling | 8 | 2022 | 17 | 1.830 |
Why?
| Calcium Channels, N-Type | 2 | 2025 | 10 | 1.690 |
Why?
| Nerve Tissue Proteins | 5 | 2018 | 569 | 1.680 |
Why?
| Muscle Proteins | 15 | 2017 | 220 | 1.610 |
Why?
| Muscular Diseases | 11 | 2016 | 107 | 1.370 |
Why?
| Malignant Hyperthermia | 6 | 2023 | 8 | 1.300 |
Why?
| Cell Membrane | 11 | 2025 | 730 | 1.240 |
Why?
| Membrane Proteins | 3 | 2025 | 1115 | 1.190 |
Why?
| Neurons | 8 | 2021 | 1493 | 1.160 |
Why?
| Membrane Potentials | 23 | 2013 | 291 | 1.150 |
Why?
| Cells, Cultured | 39 | 2018 | 4072 | 1.020 |
Why?
| Mice | 77 | 2023 | 16861 | 1.020 |
Why?
| Animals | 114 | 2025 | 35219 | 1.020 |
Why?
| Luminescent Proteins | 10 | 2012 | 175 | 0.970 |
Why?
| Animals, Newborn | 20 | 2018 | 826 | 0.930 |
Why?
| Mutation | 13 | 2023 | 3715 | 0.810 |
Why?
| Endoplasmic Reticulum | 2 | 2025 | 259 | 0.810 |
Why?
| Electrophysiology | 24 | 2012 | 210 | 0.760 |
Why?
| Action Potentials | 16 | 2022 | 485 | 0.750 |
Why?
| Sarcoplasmic Reticulum | 13 | 2017 | 45 | 0.750 |
Why?
| Recombinant Fusion Proteins | 12 | 2016 | 643 | 0.700 |
Why?
| Mutation, Missense | 3 | 2013 | 317 | 0.700 |
Why?
| Caveolin 1 | 3 | 2017 | 19 | 0.700 |
Why?
| Motor Neurons | 9 | 1999 | 236 | 0.670 |
Why?
| Rabbits | 19 | 2018 | 778 | 0.610 |
Why?
| Cell Line | 10 | 2021 | 2777 | 0.570 |
Why?
| Ion Channels | 9 | 1988 | 130 | 0.540 |
Why?
| Myocardium | 11 | 2012 | 976 | 0.540 |
Why?
| Mice, Mutant Strains | 17 | 2012 | 298 | 0.520 |
Why?
| HEK293 Cells | 3 | 2025 | 693 | 0.500 |
Why?
| Mutant Proteins | 1 | 2016 | 99 | 0.500 |
Why?
| Amino Acid Sequence | 16 | 2015 | 2056 | 0.500 |
Why?
| DNA, Complementary | 15 | 2012 | 270 | 0.490 |
Why?
| Protein Binding | 9 | 2025 | 2119 | 0.480 |
Why?
| Calcium Channel Blockers | 11 | 2009 | 159 | 0.470 |
Why?
| Myoblasts, Skeletal | 2 | 2010 | 12 | 0.430 |
Why?
| Molecular Sequence Data | 15 | 2015 | 2830 | 0.430 |
Why?
| Kinetics | 15 | 2016 | 1641 | 0.430 |
Why?
| Heart | 5 | 2001 | 637 | 0.420 |
Why?
| Neuromuscular Junction | 5 | 2009 | 58 | 0.410 |
Why?
| Dihydropyridines | 9 | 2003 | 15 | 0.410 |
Why?
| Ryanodine | 3 | 2009 | 15 | 0.400 |
Why?
| Protein Subunits | 6 | 2016 | 234 | 0.400 |
Why?
| 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester | 7 | 2013 | 11 | 0.390 |
Why?
| Receptors, Nicotinic | 10 | 1991 | 328 | 0.380 |
Why?
| Adaptor Proteins, Signal Transducing | 4 | 2022 | 398 | 0.360 |
Why?
| Patch-Clamp Techniques | 9 | 2010 | 275 | 0.350 |
Why?
| Muscle, Striated | 1 | 2010 | 6 | 0.350 |
Why?
| Purkinje Cells | 3 | 1999 | 71 | 0.330 |
Why?
| Sodium Channels | 3 | 1999 | 63 | 0.330 |
Why?
| Binding Sites | 6 | 2018 | 1249 | 0.320 |
Why?
| Protein Structure, Tertiary | 6 | 2015 | 837 | 0.320 |
Why?
| Myofibrils | 1 | 2009 | 49 | 0.310 |
Why?
| Microtubules | 4 | 1999 | 262 | 0.310 |
Why?
| Calcium Channel Agonists | 4 | 2013 | 12 | 0.310 |
Why?
| Synaptic Transmission | 4 | 2009 | 269 | 0.300 |
Why?
| Protein Conformation | 9 | 2010 | 857 | 0.300 |
Why?
| Monomeric GTP-Binding Proteins | 1 | 2008 | 10 | 0.290 |
Why?
| Transfection | 7 | 2012 | 908 | 0.290 |
Why?
| Streptavidin | 1 | 2007 | 14 | 0.290 |
Why?
| Spinal Cord | 3 | 1999 | 356 | 0.270 |
Why?
| Structure-Activity Relationship | 7 | 2010 | 548 | 0.250 |
Why?
| Green Fluorescent Proteins | 6 | 2005 | 385 | 0.250 |
Why?
| Protein Structure, Secondary | 6 | 2012 | 341 | 0.240 |
Why?
| Protein Conformation, alpha-Helical | 1 | 2025 | 15 | 0.240 |
Why?
| omega-Conotoxins | 2 | 1996 | 4 | 0.230 |
Why?
| Electric Conductivity | 11 | 2001 | 94 | 0.230 |
Why?
| Protein Isoforms | 2 | 2021 | 390 | 0.230 |
Why?
| Potassium | 5 | 2006 | 141 | 0.220 |
Why?
| Models, Biological | 8 | 2010 | 1718 | 0.220 |
Why?
| Halothane | 1 | 2023 | 6 | 0.220 |
Why?
| Protein Domains | 1 | 2025 | 253 | 0.210 |
Why?
| Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2023 | 10 | 0.210 |
Why?
| Fluorescent Dyes | 3 | 2001 | 315 | 0.210 |
Why?
| Rats | 14 | 2018 | 5462 | 0.210 |
Why?
| Recombinant Proteins | 5 | 2014 | 1303 | 0.200 |
Why?
| Heat-Shock Response | 1 | 2023 | 72 | 0.200 |
Why?
| Sequence Homology, Amino Acid | 6 | 2008 | 371 | 0.200 |
Why?
| Myocardial Contraction | 3 | 2012 | 335 | 0.200 |
Why?
| Sinoatrial Node | 1 | 2022 | 27 | 0.200 |
Why?
| Fluorescence Resonance Energy Transfer | 3 | 2012 | 177 | 0.200 |
Why?
| Microscopy, Confocal | 4 | 2005 | 310 | 0.190 |
Why?
| Sodium | 5 | 2011 | 202 | 0.190 |
Why?
| Signal Transduction | 9 | 2017 | 4913 | 0.190 |
Why?
| Fluoresceins | 1 | 2001 | 48 | 0.190 |
Why?
| Calcium Channels, T-Type | 1 | 2003 | 83 | 0.190 |
Why?
| Cysteine | 2 | 2005 | 194 | 0.180 |
Why?
| Cytoplasm | 3 | 2012 | 263 | 0.180 |
Why?
| Bacterial Proteins | 4 | 2012 | 835 | 0.180 |
Why?
| Mice, Knockout | 4 | 2016 | 2856 | 0.180 |
Why?
| Organometallic Compounds | 1 | 2001 | 107 | 0.170 |
Why?
| Humans | 20 | 2025 | 129212 | 0.170 |
Why?
| Cerebellum | 2 | 2018 | 218 | 0.170 |
Why?
| Lambert-Eaton Myasthenic Syndrome | 2 | 1996 | 3 | 0.170 |
Why?
| Caffeine | 6 | 2012 | 62 | 0.170 |
Why?
| Receptor Cross-Talk | 1 | 1999 | 21 | 0.160 |
Why?
| Manganese | 2 | 2009 | 61 | 0.150 |
Why?
| Biotinylation | 2 | 2012 | 29 | 0.150 |
Why?
| Prosencephalon | 1 | 2018 | 44 | 0.150 |
Why?
| Mice, Neurologic Mutants | 1 | 1998 | 20 | 0.150 |
Why?
| Electric Stimulation | 8 | 2004 | 268 | 0.150 |
Why?
| Myocytes, Cardiac | 1 | 2022 | 496 | 0.150 |
Why?
| Blood Proteins | 1 | 2000 | 242 | 0.150 |
Why?
| Mice, Transgenic | 4 | 2012 | 2111 | 0.150 |
Why?
| Alternative Splicing | 1 | 1999 | 218 | 0.140 |
Why?
| Nervous System Diseases | 1 | 2000 | 252 | 0.140 |
Why?
| Mutagenesis, Site-Directed | 4 | 2005 | 361 | 0.140 |
Why?
| Ions | 2 | 2008 | 66 | 0.140 |
Why?
| Chimera | 2 | 1996 | 59 | 0.130 |
Why?
| Gene Expression Regulation | 3 | 2016 | 2543 | 0.130 |
Why?
| Subcellular Fractions | 1 | 2016 | 81 | 0.130 |
Why?
| Electrophysiological Phenomena | 1 | 2016 | 54 | 0.120 |
Why?
| Proteins | 1 | 2001 | 939 | 0.120 |
Why?
| Polymerase Chain Reaction | 3 | 2004 | 1036 | 0.120 |
Why?
| Calmodulin | 2 | 2008 | 76 | 0.120 |
Why?
| Oxadiazoles | 2 | 1992 | 33 | 0.120 |
Why?
| Fluorescence | 2 | 2012 | 159 | 0.120 |
Why?
| Receptors, Purinergic P1 | 1 | 1994 | 26 | 0.110 |
Why?
| DNA | 7 | 1993 | 1399 | 0.110 |
Why?
| Motor Endplate | 3 | 1986 | 15 | 0.110 |
Why?
| Bone and Bones | 1 | 1996 | 298 | 0.110 |
Why?
| Plasmids | 6 | 1994 | 358 | 0.110 |
Why?
| Hippocampus | 1 | 2018 | 856 | 0.100 |
Why?
| Cell Fusion | 2 | 1990 | 51 | 0.100 |
Why?
| Rats, Sprague-Dawley | 1 | 2018 | 2387 | 0.100 |
Why?
| Triclosan | 1 | 2012 | 9 | 0.100 |
Why?
| Adenosine | 1 | 1994 | 224 | 0.100 |
Why?
| Molecular Docking Simulation | 1 | 2012 | 109 | 0.100 |
Why?
| Anti-Infective Agents, Local | 1 | 2012 | 42 | 0.100 |
Why?
| Time Factors | 6 | 2010 | 6549 | 0.100 |
Why?
| Biotin | 1 | 2012 | 23 | 0.100 |
Why?
| Barium | 4 | 1998 | 27 | 0.100 |
Why?
| Cloning, Molecular | 3 | 2001 | 524 | 0.090 |
Why?
| Fibroblasts | 3 | 1990 | 944 | 0.090 |
Why?
| Sarcomeres | 2 | 2009 | 92 | 0.080 |
Why?
| Amino Acid Substitution | 2 | 2002 | 282 | 0.080 |
Why?
| Muscle Development | 4 | 1993 | 103 | 0.080 |
Why?
| Dantrolene | 1 | 2009 | 5 | 0.080 |
Why?
| Oligopeptides | 2 | 2001 | 256 | 0.080 |
Why?
| Nifedipine | 1 | 2009 | 29 | 0.080 |
Why?
| Hindlimb | 1 | 1989 | 122 | 0.080 |
Why?
| Neuromuscular Diseases | 1 | 1990 | 105 | 0.080 |
Why?
| Point Mutation | 2 | 2001 | 225 | 0.080 |
Why?
| Night Blindness | 1 | 2008 | 6 | 0.080 |
Why?
| Ataxia | 1 | 2008 | 42 | 0.070 |
Why?
| Muscular Dystrophies | 1 | 1988 | 35 | 0.070 |
Why?
| In Vitro Techniques | 3 | 1997 | 1083 | 0.070 |
Why?
| Embryo, Nonmammalian | 1 | 1988 | 166 | 0.070 |
Why?
| Cytosol | 1 | 2008 | 218 | 0.070 |
Why?
| Embryo, Mammalian | 1 | 1988 | 225 | 0.070 |
Why?
| Heterozygote | 1 | 2008 | 272 | 0.070 |
Why?
| Protein Interaction Mapping | 1 | 2007 | 108 | 0.070 |
Why?
| Mutagenesis | 2 | 2001 | 181 | 0.070 |
Why?
| Biophysical Phenomena | 2 | 1997 | 64 | 0.070 |
Why?
| Biophysics | 2 | 1997 | 68 | 0.070 |
Why?
| Receptors, Cholinergic | 4 | 1990 | 38 | 0.070 |
Why?
| Taste | 1 | 1988 | 215 | 0.060 |
Why?
| Genes, Lethal | 1 | 1986 | 29 | 0.060 |
Why?
| Temperature | 3 | 1985 | 632 | 0.060 |
Why?
| Chick Embryo | 3 | 1991 | 130 | 0.060 |
Why?
| Mice, Inbred C57BL | 3 | 2012 | 5408 | 0.060 |
Why?
| Analysis of Variance | 2 | 2012 | 1285 | 0.060 |
Why?
| Xanthenes | 2 | 1994 | 10 | 0.060 |
Why?
| Reference Values | 2 | 1996 | 793 | 0.060 |
Why?
| Repetitive Sequences, Nucleic Acid | 2 | 1997 | 111 | 0.060 |
Why?
| Ganglia, Spinal | 2 | 1996 | 73 | 0.050 |
Why?
| Age Factors | 3 | 2012 | 3137 | 0.050 |
Why?
| Aniline Compounds | 2 | 1994 | 97 | 0.050 |
Why?
| Genetic Predisposition to Disease | 1 | 2012 | 2281 | 0.050 |
Why?
| Rats, Inbred Strains | 4 | 1985 | 368 | 0.050 |
Why?
| Potassium Channels | 2 | 1997 | 147 | 0.050 |
Why?
| Carrier Proteins | 1 | 2007 | 740 | 0.050 |
Why?
| Light | 1 | 2005 | 353 | 0.050 |
Why?
| Magnesium | 1 | 2003 | 152 | 0.050 |
Why?
| Isradipine | 2 | 1995 | 4 | 0.050 |
Why?
| RNA, Messenger | 3 | 1998 | 2702 | 0.050 |
Why?
| Models, Structural | 3 | 1997 | 39 | 0.050 |
Why?
| Receptors, Adrenergic, beta | 1 | 2022 | 126 | 0.050 |
Why?
| Allosteric Regulation | 1 | 2001 | 98 | 0.050 |
Why?
| Restriction Mapping | 2 | 1999 | 75 | 0.050 |
Why?
| Indicators and Reagents | 1 | 2001 | 109 | 0.050 |
Why?
| CHO Cells | 1 | 2001 | 152 | 0.050 |
Why?
| Lipid Bilayers | 1 | 2002 | 98 | 0.050 |
Why?
| Cricetinae | 1 | 2001 | 277 | 0.050 |
Why?
| Amiloride | 2 | 1992 | 24 | 0.050 |
Why?
| Spectrometry, Fluorescence | 1 | 2001 | 171 | 0.040 |
Why?
| Culture Techniques | 2 | 1991 | 80 | 0.040 |
Why?
| Cyclic GMP | 2 | 1978 | 88 | 0.040 |
Why?
| Tetrodotoxin | 3 | 1990 | 39 | 0.040 |
Why?
| Two-Hybrid System Techniques | 1 | 2000 | 56 | 0.040 |
Why?
| Microscopy, Electron | 3 | 2012 | 425 | 0.040 |
Why?
| Mammals | 1 | 2002 | 269 | 0.040 |
Why?
| NAV1.6 Voltage-Gated Sodium Channel | 1 | 1999 | 10 | 0.040 |
Why?
| Tetraethylammonium Compounds | 2 | 1990 | 9 | 0.040 |
Why?
| Peptides | 2 | 1996 | 924 | 0.040 |
Why?
| Phosphodiesterase Inhibitors | 1 | 2000 | 89 | 0.040 |
Why?
| Adenosine Triphosphate | 1 | 2002 | 477 | 0.040 |
Why?
| Protein Folding | 1 | 2001 | 266 | 0.040 |
Why?
| Conserved Sequence | 2 | 1997 | 227 | 0.040 |
Why?
| Mice, Inbred Strains | 1 | 2000 | 406 | 0.040 |
Why?
| Magnetic Resonance Spectroscopy | 1 | 2001 | 538 | 0.040 |
Why?
| Heart Failure | 1 | 2012 | 2147 | 0.040 |
Why?
| Microscopy, Fluorescence | 1 | 2000 | 400 | 0.040 |
Why?
| omega-Agatoxin IVA | 1 | 1998 | 1 | 0.040 |
Why?
| Heart Rate | 1 | 2022 | 800 | 0.040 |
Why?
| Spider Venoms | 1 | 1998 | 11 | 0.040 |
Why?
| Microelectrodes | 2 | 2012 | 43 | 0.040 |
Why?
| Cell Compartmentation | 1 | 1998 | 52 | 0.040 |
Why?
| Mice, Inbred C3H | 1 | 1998 | 273 | 0.040 |
Why?
| Cell Nucleus | 1 | 2001 | 582 | 0.040 |
Why?
| Zebrafish | 1 | 2022 | 458 | 0.040 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 1998 | 133 | 0.040 |
Why?
| Gene Expression | 1 | 2003 | 1469 | 0.040 |
Why?
| Shaker Superfamily of Potassium Channels | 1 | 1997 | 3 | 0.040 |
Why?
| Mutagenesis, Insertional | 1 | 1997 | 65 | 0.040 |
Why?
| Saccharomyces cerevisiae | 1 | 2001 | 532 | 0.030 |
Why?
| Electrochemistry | 1 | 1997 | 80 | 0.030 |
Why?
| Macromolecular Substances | 1 | 1997 | 213 | 0.030 |
Why?
| Sequence Alignment | 1 | 1997 | 331 | 0.030 |
Why?
| Nimodipine | 1 | 1996 | 8 | 0.030 |
Why?
| Leucine | 1 | 1997 | 108 | 0.030 |
Why?
| Papillary Muscles | 1 | 1996 | 14 | 0.030 |
Why?
| Protein Multimerization | 1 | 2017 | 179 | 0.030 |
Why?
| Peptide Fragments | 1 | 2000 | 690 | 0.030 |
Why?
| Gap Junctions | 1 | 1997 | 60 | 0.030 |
Why?
| Protein Transport | 1 | 2017 | 425 | 0.030 |
Why?
| Blood | 1 | 1996 | 103 | 0.030 |
Why?
| Molecular Structure | 1 | 1997 | 480 | 0.030 |
Why?
| Snakes | 2 | 1986 | 20 | 0.030 |
Why?
| Models, Molecular | 1 | 2000 | 1487 | 0.030 |
Why?
| Cadmium Chloride | 1 | 1995 | 4 | 0.030 |
Why?
| Barium Compounds | 1 | 1995 | 8 | 0.030 |
Why?
| Lanthanum | 1 | 1995 | 13 | 0.030 |
Why?
| Cadmium | 1 | 1995 | 67 | 0.030 |
Why?
| omega-Conotoxin GVIA | 1 | 1994 | 4 | 0.030 |
Why?
| Adenosine-5'-(N-ethylcarboxamide) | 1 | 1994 | 11 | 0.030 |
Why?
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1994 | 20 | 0.030 |
Why?
| Cell Membrane Permeability | 1 | 1994 | 81 | 0.030 |
Why?
| Reaction Time | 1 | 1996 | 408 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 1997 | 345 | 0.030 |
Why?
| Membranes | 1 | 1994 | 20 | 0.030 |
Why?
| Chlorides | 1 | 1995 | 139 | 0.030 |
Why?
| Egtazic Acid | 1 | 1994 | 41 | 0.030 |
Why?
| Phosphorylation | 1 | 1998 | 1710 | 0.030 |
Why?
| Heterocyclic Compounds, 3-Ring | 1 | 1994 | 31 | 0.030 |
Why?
| Swine | 1 | 1996 | 757 | 0.030 |
Why?
| 3T3 Cells | 1 | 1993 | 151 | 0.030 |
Why?
| Synapses | 2 | 1996 | 391 | 0.030 |
Why?
| Nicotinic Acids | 1 | 1992 | 6 | 0.030 |
Why?
| Mathematics | 2 | 1983 | 102 | 0.030 |
Why?
| Water Pollutants | 1 | 2012 | 20 | 0.020 |
Why?
| Cyprinidae | 1 | 2012 | 20 | 0.020 |
Why?
| Protein Structure, Quaternary | 1 | 2012 | 122 | 0.020 |
Why?
| Genes, Dominant | 1 | 2012 | 92 | 0.020 |
Why?
| Organ Specificity | 1 | 1993 | 295 | 0.020 |
Why?
| Algorithms | 1 | 1999 | 1618 | 0.020 |
Why?
| Anesthetics | 1 | 2012 | 63 | 0.020 |
Why?
| Sequence Homology, Nucleic Acid | 1 | 1991 | 150 | 0.020 |
Why?
| Body Temperature | 1 | 2012 | 212 | 0.020 |
Why?
| Tetraethylammonium | 1 | 1990 | 17 | 0.020 |
Why?
| Cell Death | 1 | 1992 | 354 | 0.020 |
Why?
| 4-Aminopyridine | 1 | 1990 | 24 | 0.020 |
Why?
| Peptides, Cyclic | 1 | 1992 | 256 | 0.020 |
Why?
| Phylogeny | 1 | 1993 | 849 | 0.020 |
Why?
| Extremities | 1 | 1990 | 127 | 0.020 |
Why?
| beta-Galactosidase | 1 | 1989 | 76 | 0.020 |
Why?
| Tropomyosin | 1 | 1989 | 12 | 0.020 |
Why?
| Freeze Fracturing | 2 | 2002 | 5 | 0.020 |
Why?
| DNA Probes | 1 | 1989 | 61 | 0.020 |
Why?
| Male | 5 | 2008 | 63491 | 0.020 |
Why?
| Muscular Dystrophy, Animal | 1 | 1989 | 8 | 0.020 |
Why?
| Verapamil | 1 | 1989 | 41 | 0.020 |
Why?
| Creatine Kinase | 1 | 1989 | 73 | 0.020 |
Why?
| Embryonic and Fetal Development | 1 | 1989 | 94 | 0.020 |
Why?
| Sarcolemma | 1 | 1989 | 40 | 0.020 |
Why?
| Gestational Age | 1 | 1992 | 872 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 1989 | 189 | 0.020 |
Why?
| Base Sequence | 1 | 1992 | 2141 | 0.020 |
Why?
| Necturus | 1 | 1988 | 14 | 0.020 |
Why?
| Myosins | 1 | 1989 | 133 | 0.020 |
Why?
| Stem Cell Transplantation | 1 | 1990 | 166 | 0.020 |
Why?
| Genetic Markers | 1 | 1989 | 338 | 0.020 |
Why?
| Dystrophin | 1 | 1988 | 34 | 0.020 |
Why?
| Stereoisomerism | 1 | 1988 | 98 | 0.020 |
Why?
| Genes | 1 | 1988 | 226 | 0.020 |
Why?
| Amino Acid Motifs | 1 | 2008 | 213 | 0.020 |
Why?
| Motor Activity | 1 | 2012 | 676 | 0.020 |
Why?
| Dimerization | 1 | 2008 | 191 | 0.020 |
Why?
| Brain | 2 | 1997 | 2664 | 0.020 |
Why?
| Chromosome Mapping | 1 | 1988 | 504 | 0.020 |
Why?
| Actins | 1 | 1989 | 408 | 0.020 |
Why?
| Transcription, Genetic | 1 | 1993 | 1415 | 0.020 |
Why?
| Histological Techniques | 1 | 1986 | 40 | 0.020 |
Why?
| Tissue Distribution | 1 | 1986 | 315 | 0.020 |
Why?
| Cations | 1 | 2005 | 79 | 0.020 |
Why?
| Stem Cells | 1 | 1990 | 577 | 0.020 |
Why?
| Tendons | 1 | 1986 | 106 | 0.010 |
Why?
| Biological Transport, Active | 1 | 1985 | 78 | 0.010 |
Why?
| Female | 2 | 2008 | 68600 | 0.010 |
Why?
| Rubidium | 1 | 1983 | 12 | 0.010 |
Why?
| Evoked Potentials | 1 | 1983 | 116 | 0.010 |
Why?
| Kidney | 1 | 1989 | 1375 | 0.010 |
Why?
| Cell Differentiation | 1 | 1989 | 1899 | 0.010 |
Why?
| Liver | 1 | 1989 | 1838 | 0.010 |
Why?
| Rana pipiens | 2 | 1978 | 17 | 0.010 |
Why?
| Tumor Cells, Cultured | 2 | 1993 | 939 | 0.010 |
Why?
| Pregnancy | 1 | 1992 | 6384 | 0.010 |
Why?
| Thoracica | 1 | 1977 | 2 | 0.010 |
Why?
| Potassium Chloride | 1 | 1977 | 40 | 0.010 |
Why?
| Glutamates | 1 | 1977 | 56 | 0.010 |
Why?
| Ethylamines | 1 | 1976 | 5 | 0.010 |
Why?
| Lidocaine | 1 | 1976 | 39 | 0.010 |
Why?
| Organ Culture Techniques | 1 | 1996 | 154 | 0.010 |
Why?
| Methylamines | 1 | 1976 | 30 | 0.010 |
Why?
| Gene Targeting | 1 | 1996 | 82 | 0.010 |
Why?
| Ca(2+) Mg(2+)-ATPase | 1 | 1989 | 2 | 0.000 |
Why?
| Calsequestrin | 1 | 1989 | 8 | 0.000 |
Why?
| Calcium-Transporting ATPases | 1 | 1989 | 40 | 0.000 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 1988 | 69 | 0.000 |
Why?
| Molecular Weight | 1 | 1989 | 331 | 0.000 |
Why?
| Pheochromocytoma | 1 | 1989 | 57 | 0.000 |
Why?
| Cell Communication | 1 | 1989 | 300 | 0.000 |
Why?
| Anura | 1 | 1978 | 40 | 0.000 |
Why?
| Cyclic AMP | 1 | 1978 | 237 | 0.000 |
Why?
|
|
Beam's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|